Isolation of cmr, a novel Escherichia coli chloramphenicol resistance gene encoding a putative efflux pump

I W Nilsen1, I Bakke, A Vader

  • 1Department of Biotechnology, Institute of Medical Biology, University of Tromsø, Norway.

Insights

A newly discovered gene, cmr, in Escherichia coli K-12 confers resistance to chloramphenicol. This gene actively excludes the antibiotic, significantly reducing its accumulation in bacterial cells.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Background:

  • Chloramphenicol is a broad-spectrum antibiotic.
  • Antibiotic resistance is a growing global health concern.
  • Understanding resistance mechanisms is crucial for developing new treatments.

Purpose of the Study:

  • To identify and characterize a novel gene conferring chloramphenicol resistance in Escherichia coli.
  • To elucidate the mechanism of chloramphenicol resistance mediated by the identified gene.

Main Methods:

  • Gene mapping and cloning in Escherichia coli K-12.
  • Gene expression analysis using Northern (RNA) blot.
  • Chloramphenicol accumulation assays with and without proton motive force blockers.
  • Sequence analysis of the novel gene and its protein product.

Main Results:

  • A novel gene, cmr, was identified and mapped to the Escherichia coli K-12 genome.
  • Overexpression of cmr significantly reduced chloramphenicol accumulation in bacterial cells.
  • Northern blot analysis confirmed cmr expression as a 1.3-kb transcript.
  • Sequence analysis revealed Cmr protein shares similarities with major facilitator family drug resistance proteins.
  • Evidence suggests active exclusion of chloramphenicol as the resistance mechanism.

Conclusions:

  • The novel cmr gene confers chloramphenicol resistance in Escherichia coli.
  • The Cmr protein likely functions as an efflux pump, actively excluding chloramphenicol.
  • This finding contributes to understanding antibiotic resistance mechanisms in bacteria.